Chardan Healthcare Acquisition 2 Corp (CHAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CHAQ | BRNS | PASG | ||
Company | Chardan Healthcare Acquisition 2 Corp | Barinthus Biotherapeutics Plc ADR | Passage Bio Inc | ||
Price Information | |||||
Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
Open | 9.35 | 2.23 | 1.4900 | ||
High | 9.35 | 2.42 | 1.5500 | ||
Low | 8.06 | 2.20 | 1.4412 | ||
Last | 8.41 | 2.35 | 1.4800 | ||
Change | -0.95 | +0.01 | +0.0100 | ||
% Change | -10.15% | +0.43% | +0.68% | ||
Volume | 242,600 | 7,400 | 32,300 | ||
20-Day Average Volume | 87,520 | 16,340 | 112,315 | ||
Previous Close | 9.36 | 2.34 | 1.4700 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.87 | 2.40 | 1.3250 | ||
20-Day Raw Stochastic | 14.23% | 55.26% | 70.34% | ||
20-Day Relative Strength | 17.92% | 45.59% | 56.69% | ||
Weighted Alpha | -24.94 | -43.06 | +38.81 | ||
Today's Opinion | 100% Sell | 88% Sell | 88% Buy | ||
Previous Opinion | 100% Sell | 88% Sell | 88% Buy | ||
Last Month's Opinion | 40% Sell | 24% Buy | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -16.07% since 08/26/21 | +6.11% since 05/06/24 | +4.96% since 05/06/24 | ||
Low | 8.06 on 09/02/21 | 2.20 on 05/13/24 | 1.4200 on 05/10/24 | ||
High | 10.52 on 08/30/21 | 2.45 on 05/10/24 | 1.6400 on 05/08/24 | ||
1-Month | |||||
%Chg | -16.65% since 08/02/21 | -25.32% since 04/12/24 | +10.45% since 04/12/24 | ||
Low | 8.06 on 09/02/21 | 1.82 on 04/30/24 | 1.1006 on 04/23/24 | ||
High | 10.52 on 08/30/21 | 2.97 on 04/15/24 | 1.6400 on 05/08/24 | ||
3-Month | |||||
%Chg | -16.36% since 06/02/21 | -9.46% since 02/13/24 | +49.49% since 02/13/24 | ||
Low | 8.06 on 09/02/21 | 1.82 on 04/30/24 | 0.9430 on 02/14/24 | ||
High | 10.52 on 08/30/21 | 4.16 on 04/04/24 | 1.7900 on 03/06/24 | ||
6-Month | |||||
%Chg | -17.39% since 03/02/21 | -15.34% since 11/13/23 | +146.67% since 11/13/23 | ||
Low | 8.06 on 09/02/21 | 1.82 on 04/30/24 | 0.5841 on 11/24/23 | ||
High | 10.52 on 08/30/21 | 4.16 on 04/04/24 | 1.7900 on 03/06/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 90,643 | 90,881 | 90,570 | ||
Shares Outstanding, K | 10,778 | 38,921 | 61,612 | ||
Annual Sales | 0 | 800,000 | 0 | ||
Annual Net Income | -780,000 | -73,350,000 | -102,060,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -490,000 | -14,070,000 | -16,760,000 | ||
60-Month Beta | 0.05 | -0.45 | 1.28 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.45 on 03/20/24 | -0.30 on 03/04/24 | ||
Latest Earnings Date | N/A | 05/10/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |